SCHEMBL13825940

SCHEMBL13825940

CC1(C(=O)N2CCOCC2)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.60
SMN1; SMN2 Q16637 4/20 0.50
ALDH1A1 P00352 2/20 0.47
NPSR1 Q6W5P4 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
MAPK1 P28482 1/20 0.46
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA9 Q16790 1/20 0.45
MEN1 O00255 1/20 0.43
TP53 P04637 1/20 0.43
KMT2A Q03164 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C19 P33261 1/20 0.43
HTT P42858 1/20 0.42
TSHR P16473 1/20 0.42
MMP1 P03956 1/20 0.42
MMP3 P08254 1/20 0.42
MMP8 P22894 1/20 0.42
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12605736 0.92 GAA (0.56) GAASMN1; SMN2ALDH1A1NPSR1L3MBTL1
SCHEMBL14654216 0.85 GAA (0.58) GAASMN1; SMN2ALDH1A1NPSR1L3MBTL1
SCHEMBL517174 0.84 ALDH1A1 (0.50) GAASMN1; SMN2ALDH1A1NPSR1L3MBTL1
SCHEMBL23369804 0.80 GAA (0.58) GAASMN1; SMN2ALDH1A1NPSR1L3MBTL1
SCHEMBL17192621 0.79 ALDH1A1 (0.44) GAASMN1; SMN2ALDH1A1L3MBTL1MAPK1
SCHEMBL5986262 0.79 FFAR3 (0.42) GAASMN1; SMN2ALDH1A1L3MBTL1MAPK1
SCHEMBL12310562 0.78 GAA (0.55) GAASMN1; SMN2ALDH1A1NPSR1L3MBTL1
SCHEMBL29774522 0.77 GAA (0.42) GAASMN1; SMN2ALDH1A1NPSR1L3MBTL1
SCHEMBL30268155 0.77 ALDH1A1 (0.47) GAASMN1; SMN2ALDH1A1NPSR1L3MBTL1
SCHEMBL8379452 0.76 HSD11B1 (0.50) L3MBTL1HTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016109217-A2 BTK INHIBITORS MERCK SHARP & DOHME CORP. (US) 2016-07-07 WO disclosed
WO-2016106627-A1 BTK INHIBITORS MERCK SHARP & DOHME CORP. (US) 2016-07-07 WO disclosed
WO-2012154249-A1 SUBSTITUTED AMINOBUTYRIC DERIVATIVES AS NEPRILYSIN INHIBITORS THERAVANCE, INC. (US) 2012-11-15 WO disclosed